Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for October 21, 2009 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Donald Brown, ND, to give Keynote Presentation on Pelargonium Sidoides Extract at the Arizona Naturopathic Medical Association Fall Convention
Dr. Donald Brown will discuss the merits of the Pelargonium sidoides Extract EPs 7630 for the treatment of acute upper respiratory infections at the Arizona Naturopathic Medical Association Fall Convention in Tempe, Arizona. 
x-small text small text medium text large text


    GREEN BAY, WI, October 21, 2009 /24-7PressRelease/ -- Dr. Donald Brown, a naturopathic physician and one of the leading US authorities on evidence-based herbal medicine, will be a keynote speaker at the Arizona Naturopathic Medical Association convention on Saturday, November 14th in Tempe, Arizona. His presentation will feature EPs 7630, a proprietary extract of the root of Pelargonium sidoides, and he will discuss the safety and efficacy data that supports its use in the treatment of acute upper respiratory infections in both adults and children. Particular focus will be given to the safety of the product in children as young as 2 years of age and its use as an alternative to OTC cough and cold products.

Currently Vice President, Medical and Educational Affairs for Schwabe North America, Inc. and its subsidiaries Integrative Therapeutics , Nature's Way , and Enzymatic Therapy , Dr. Brown is an expert and published author on the safety and efficacy of herbal medicines and nutritional supplements.

Extensive clinical research and pharmacovigilance have found EPs 7630 to safely and effectively shorten the duration and severity of the common cold, acute bronchitis, acute non-strep tonsillopharyngitis, and acute sinusitis. The active ingredient is contained in ViraClear EPs 7630 and sold by Integrative Therapeutics to health care professionals in the U.S.

"Many conventional remedies for acute upper respiratory tract infections only affect the symptoms - they rarely address the cause," explains Dr. Brown. "With EPs 7630, practitioners and patients - including young children - have a clinically proven way to fight back naturally."

In March 2008, the Journal of Family Practice commented on Pelargonium sidoides (EPs 7630), "Our conclusion is that patients could be advised to purchase the medication to have on hand at home at the start of the cold season."

About Integrative Therapeutics, Inc.

Integrative Therapeutics, Inc. manufactures and distributes proprietary, natural, dietary supplements for medical professionals and their patients. Its manufacturing facility meets stringent quality standards and is organically certified and an FDA-registered drug establishment. Every day, more than 50,000 doctors recommend clinically proven, safe and effective Integrative Therapeutics products to their patients. Find out more at http://www.integrativeinc.com.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Read more Press Releases from Tara Brown:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Tara Brown
Integrative Therapeutics, Inc.

Community Strategist
825 Challenger Dr
Green Bay, WI
United States 54311
Voice: 920-469-1313 x1317
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.